Cargando…
Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence
AIM: Half of heart failure (HF) patients have chronic kidney disease (CKD) complicating their pharmacological management. We evaluated physicians' and patients' patterns of use of evidence‐based medical therapies in HF across CKD stages. METHODS AND RESULTS: We studied HF patients with red...
Autores principales: | Janse, Roemer J., Fu, Edouard L., Dahlström, Ulf, Benson, Lina, Lindholm, Bengt, van Diepen, Merel, Dekker, Friedo W., Lund, Lars H., Carrero, Juan‐Jesus, Savarese, Gianluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087537/ https://www.ncbi.nlm.nih.gov/pubmed/35851740 http://dx.doi.org/10.1002/ejhf.2620 |
Ejemplares similares
-
Stopping versus continuing renin–angiotensin–system inhibitors after acute
kidney injury and adverse clinical outcomes: an observational study from routine care
data
por: Janse, Roemer J, et al.
Publicado: (2022) -
Tadalafil in patients on antihypertensive medications: Does safety remain an issue?
por: Theofilis, Panagiotis, et al.
Publicado: (2022) -
Analysis of integrated clinical safety data of tadalafil in patients receiving concomitant antihypertensive medications
por: Kloner, Robert A., et al.
Publicado: (2022) -
Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
por: Jackson, Alice M., et al.
Publicado: (2022) -
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2013)